![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
- Combined Study from Centres in England and Baltimore (1971) Prevention of Rh haemolytic disease: final results of the 'high risk' clinical trial. British Medical Journal, 2, 607-609.
- Kleihauer E., Braun H. and Betke K. (1957) Demonstration of fetal haemoglobin in the circulating erythrocytes. Klinische Wochenschrift, 35, 637-642.
- Lee D., Contreras M., Robson, S., Rodeck C. H. and Whittle M. J. (1999) Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists. Transfusion Medicine, 9, 93-97.
- MacKenzie I. Z., Bowell P., Gregory H., Pratt G., Guest C. and Entwhistle C. C. (1999) Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. British Journal of Obstetrics and Gynaecology, 106, 492-497.
- Murphy K. W. and Whitfield C. R. (1994) Rh disease in this decade. Contemporary Reviews in Obstetrics and Gynaecology, 6, 61-67.
- National Blood Transfusion Service Immunoglobulin Working Party (1991) Recommendations for the use of anti-D Immunoglobulin. Prescribers Journal, 31, 137-145.
- Woodrow J. C. and Finn R. (1966) Transplacental haemorrhage. British Journal of Haemorrhage, 12, 297-309.
Journal of Obstetrics and Gynaecology
Volume 20, 2000 - Issue 4